BPGbio Appoints Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer Chas Bountra, Ph.D., EVP and Chief Scientific...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease...
Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for...
Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions...
ESPOO, Finland, April 16, 2026 /PRNewswire/ -- New Finnish deep-tech company aims to make ultra-early disease detection possible through single-molecule...
The Cala kIQ Plus provides new therapy modes and adaptive calibration designed to optimize tremor relief and personalize treatment Data to...
Will play key role in strengthening cross-functional execution in support of global platform, scientific capabilities and partner delivery as well...
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesine Convergence of impaired autophagy and synaptic...
BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead...
Sleep is one of the most powerful yet underutilized biomarkers in depression drug development, with objective sleep physiology offering insights...
Financing will support the ongoing Phase 1/2 trial of NEO-811 for the treatment of locally advanced or metastatic non-resectable clear...
Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive OfficerAppoints industry veterans Josh Muntner as Chief...
A full clinical intelligence platform connecting documentation, coding, and revenue in real time. NEW YORK, April 7, 2026 /PRNewswire/ --...
Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal...
BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced donations...
On World Health Day, the latest Health Futures report from VML Health suggests the next big wins in health won't...
Expands OEM Platform and Strengthens Leadership in Nuclear Medicine ImagingPITTSBURGH, April 02, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a national...
SAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth...
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light"...
BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a...